2 ASX 200 shares with enough pricing power to battle inflation: Expert

An expert has tipped Transurban and Resmed shares as potential inflation safe havens.

| More on:
a woman sits in comtemplation with superimposed images of piles of gold coins, graphs and star-like lights above her head as though she is thinking about investment options.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Rising inflation has been the talk of the town in 2022 and S&P/ASX 200 Index (ASX: XJO) shares aren't immune from its bite.

In fact, many ASX 200 technology shares have been hit hard by the shifting landscape. The S&P/ASX 200 Information Technology Index (ASX: XIJ), for example, has plunged nearly 38% year to date.

So, which ASX 200 shares can investors trust to grow their hard-earned money in 2022?

Head of Australian equities at T. Rowe Price, Randal Jenneke has flagged two stocks he believes have plenty of pricing power and could act as inflation hedges.

2 ASX 200 shares to buy in times of inflation

There are two likely ways Australia's current inflationary environment could shift, according to Jenneke.

The first – and most unlikely direction – is towards 1970s-style "stagflation". The more likely happening? Inflation continuing to rise through 2022. 

"The challenge of rising costs, whether labour or other inputs, will likely persist and contribute to higher headline inflation over the rest of the year," Jenneke said.

"[W]e will likely see investor focus shift more from top line revenue growth to margin sustainability and their volatility. We have already seen the valuation gap between high margin and high growth narrow."

And companies with strong pricing power are the most prepared to manage through such a period.

"To pass on costs effectively to buyers requires a good industry structure, differentiated products, and defensive volumes," Jenneke said.

Resmed CDI (ASX: RMD)

Fortunately, ASX 200 healthcare share Resmed has just that. Jenneke said:

Resmed … has a large under-penetrated market, and despite various input and logistics cost pressures, has been able to pass through price increases given their dominant market share and current lack of reputable competition.

The Resmed share price is currently $30.91, 14.5% lower than it was at the start of 2022.

Transurban Group (ASX: TCL)

ASX 200 infrastructure share Transurban is also set up to battle inflation, according to Jenneke, who said:

Transurban … has built-in price increases for its contracts.

The nature of its cost structure brings high [earnings before interest and tax (EBIT)] margins and margin stability. Anecdotally, you know the cost of tolls are rising when every second taxi driver makes a point or two about it.

The Transurban share price is $14.45 right now, having gained 3.6% year to date.

Finally, the expert noted, "while these are two [shares] we like, we should stress our views are supported by our fundamental insights, rather than the broader economic climate."

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Broker Notes

These ASX 200 shares could rise 20% and 50% in 2025

Analysts are tipping these shares to beat the market this year. Let's see why.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

More of the best ASX stocks to buy in 2025 according to Bell Potter

Let's see why its analysts are so bullish on these stocks this year.

Read more »

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Broker Notes

Goldman Sachs says these ASX 200 shares are buys

Let's see what the broker is saying about these big names.

Read more »

group of friends jump on the beach
Broker Notes

6 ASX All Ords shares lifted to 'strong buy' consensus ratings for the new year

Brokers upgraded these ASX stocks last month.

Read more »

Broker Notes

Why these ASX 200 stocks could be strong buys in January

Let's see why analysts are bullish on these stocks and are tipping them as buys in January.

Read more »

a man clasps his hand to his forehead as he looks down at his phone and grimaces with a pained expression on his face as he watches the Pilbara Minerals share price continue to fall
Broker Notes

Down 50% and 70%: Why these ASX 200 shares could be cheap buys

Although the S&P/ASX 200 Index (ASX: XJO) has been trading within sight of a record high, the same cannot be said…

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these stocks.

Read more »